High malignancy rate in IgE‐deficient children

Dilara Fatma Kocacik Uygun,Vedat Uygun,Ayşen Başaran,Gaye Kocatepe,Tuğba Kazlı,Ayşen Bingöl
DOI: https://doi.org/10.1002/ijc.35213
2024-10-07
International Journal of Cancer
Abstract:What's New? IgE plays specific roles in the recognition and inhibition of cancer cells as well as the maintenance of a memory response to cancer. However, the association between IgE deficiency and malignancy risk remains unclear, especially in children. In this study of 6821 pediatric patients, children with low serum IgE levels were found to have a higher rate of previous malignancy. This effect was mostly observed in hematological cancers. Meanwhile, low IgE levels in patients with suspected or diagnosed immunodeficiency did not increase the prevalence of cancer in children. Recent epidemiological studies have increasingly highlighted the antitumor efficacy of IgE owing to the increased malignancy rate in IgE‐deficient patients. The purpose of this study, the largest for children, was to determine whether malignant diagnoses in children are associated with IgE deficiency (IgE <2.5 kIU/L). A total of 6821 pediatric patients were reviewed, focusing on patients with IgE below 2.5 kIU/L (n = 599). The causes of IgE testing were evaluated by categorizing them as having cancer, allergies, suspected or diagnosed immunodeficiency, and other conditions. In all but one patient with malignancy, IgE levels were measured after the diagnosis of the disease. Malignancies were observed much more frequently in the low IgE group than in the normal group (10/599, 1.7% and 7/6222, 0.11%; OR = 15.07; 95% CI: 5.72–39.75; p
oncology
What problem does this paper attempt to address?